The relationship between lamotrigine concentration and change in resting motor threshold in a rodent model of motor cortex stimulation

Epilepsy Research

Volumn 83, Issue 2-3, 2009, Pages 103-111

  Sokal, David M ^a   Girlanda, Elena ^a   Sabattini, Giancarlo ^a   Large, Charles H ^a  

^a Medicines Research Centre   (Italy)

Author keywords

Dose response relationship; EMG; Lamotrigine; Motor cortex stimulation; Sodium channel blocker; Transcranial magnetic stimulation

Indexed keywords

LAMOTRIGINE; LIDOCAINE; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANNULATION; CORRELATION COEFFICIENT; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; HYPERACTIVITY; MALE; MOTOR ACTIVITY; NERVE EXCITABILITY; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESTING MOTOR THRESHOLD; SENSORIMOTOR CORTEX; SPRAGUE DAWLEY RAT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MODELS, ANIMAL; MOTOR CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; REST; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TRIAZINES;

EID: 58849162654     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.10.002     Document Type: Article

References (27)

1. Borckardt J.J., Nahas Z., Koola J., and George M.S. Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J. ECT 22 (2006) 169-175
2. Boroojerdi B., Battaglia F., Muellbacher W., and Cohen L.G. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin. Neurophysiol. 112 (2001) 931-937
3. Brocke J., Irlbacher K., Hauptmann B., Voss M., and Brandt S.A. Transcranial magnetic and electrical stimulation compared: does TES activate intracortical neuronal circuits?. Clin. Neurophysiol. 116 (2005) 2748-2756
4. Depondt C. The potential of pharmacogenetics in the treatment of epilepsy. Eur. J. Paediatr. Neurol. 10 (2006) 57-65
5. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Mazzone P., Insola A., Tonali P.A., and Rothwell J.C. The physiological basis of transcranial motor cortex stimulation in conscious humans. Clin. Neurophysiol. 115 (2004) 255-266
6. George M.S., Nahas Z., Kozol F.A., Li X., Yamanaka K., Mishory A., and Bohning D.E. Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr. 8 (2003) 496-514
7. Keller B.P., Haghighi S.S., Oro J.J., and Eggers Jr. G.W. The effects of propofol anesthesia on transcortical electric evoked potentials in the rat. Neurosurgery 30 (1992) 557-560
8. Lee H.W., Seo H.J., Cohen L.G., Bagic A., and Theodore W.H. Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal. Clin. Neurophysiol. 116 (2005) 1105-1112
9. Li X., Teneback C.C., Nahas Z., Kozel F.A., Large C., Cohn J., Bohning D.E., and George M.S. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 29 (2004) 1395-1407
10. Luft A.R., Kaelin-Lang A., Hauser T.K., Cohen L.G., Thakor N.V., and Hanley D.F. Transcranial magnetic stimulation in the rat. Exp. Brain Res. 140 (2001) 112-121
11. Manganotti P., Bongiovanni L.G., Zanette G., Turazzini M., and Fiaschi A. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40 (1999) 316-321
12. Messenheimer J.A. Lamotrigine. Epilepsia 36 Suppl. 2 (1995) S87-S94
13. Meyer F.P., Banditt P., Schubert A., and Schoche J. Lamotrigine concentrations in human serum, brain tissue, and tumor tissue. Epilepsia 40 (1999) 68-73
14. Nielsen J.B., Perez M.A., Oudega M., Enriquez-Denton M., and Aimonetti J.M. Evaluation of transcranial magnetic stimulation for investigating transmission in descending motor tracts in the rat. Eur. J. Neurosci. 25 (2007) 805-814
15. Nissinen J., and Pitkänen A. Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. Epilepsy Res. 73 (2007) 181-191
16. Potschka H., Fedrowitz M., and Loscher W. P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci. Lett. 327 (2002) 173-176
17. Potschka H., Fedrowitz M., and Loscher W. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR-rats. Epilepsia 44 (2003) 1479-1486
18. Rambeck B., Jurgens U.H., May T.W., Pannek H.W., Behne F., Ebner A., Gorji A., Straub H., Speckmann E.J., Pohlmann-Eden B., and Loscher W. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47 (2006) 681-694
19. Rohde V., Krombach G.A., Baumert J.H., Kreitschmann-Andermahr I., Weinzierl M., and Gilsbach J.M. Measurement of motor evoked potentials following repetitive magnetic motor cortex stimulation during isoflurane or propofol anaesthesia. Br. J. Anaesth. 91 (2003) 487-492
20. Scheufler K.M., Reinacher P.C., Blumrich W., Zentner J., and Priebe H.J. The modifying effects of stimulation pattern and propofol plasma concentration on motor-evoked potentials. Anesth. Analg. 100 (2005) 440-447
21. Tergau F., Wischer S., Somal H.S., Nitsche M.A., Mercer A.J., Paulus W., and Steinhoff B.J. Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res. 56 (2003) 67-77
22. Weiss J., Kerpen C.J., Lindenmaier H., Dormann S.M., and Haefeli W.E. Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J. Pharmacol. Exp. Ther. 307 (2003) 262-267
23. Xie X., and Hagan R.M. Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38 (1998) 119-130
24. Yamakawa K. Na channel gene mutations in epilepsy-the functional consequences. Epilepsy Res. 70 Suppl 1 (2006) S218-S222
25. Ziemann U. TMS and drugs. Clin. Neurophysiol. 115 (2004) 1717-1729
26. Ziemann U., Lonnecker S., Steinhoff B.J., and Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann. Neurol. 40 (1996) 367-378
27. Ziemann U., Tergau F., Wischer S., Hildebrandt J., and Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr. Clin. Neurophysiol. 109 (1998) 321-330